| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.26 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |